Literature DB >> 21088749

Efficacy and complications of surgery for Crohn's disease.

Robert T Lewis1, David J Maron.   

Abstract

Patients with Crohn's disease commonly undergo surgery during their lifetime. Indications for surgical intervention include obstruction, intra-abdominal or perianal abscess, enterocutaneous fistulas, and complex perianal disease. As medical therapies continue to improve, it is important that surgical therapies are chosen carefully. This is particularly important in the treatment of perianal fistulas; combined surgical and medical therapy offer the best chance for success. In the treatment of small-bowel disease, bowel preservation is key. For the repair of short strictures, endoscopic dilatation is the preferred method when accessible; strictureplasty has been shown to be safe and effective for increasingly longer segments of disease. Intra-abdominal abscesses should be drained percutaneously, if possible. In the presence of colonic disease, segmental resection is recommended. Unfortunately, refractory disease still frequently requires complete proctectomy and permanent diversion.

Entities:  

Keywords:  Crohn's disease; fistula; stricture; surgery

Year:  2010        PMID: 21088749      PMCID: PMC2976865     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  143 in total

1.  Symposium. Crohn's disease: anal lesions.

Authors:  H E Lockhart-Mummery
Journal:  Dis Colon Rectum       Date:  1975-04       Impact factor: 4.585

Review 2.  AGA technical review on perianal Crohn's disease.

Authors:  William J Sandborn; Victor W Fazio; Brian G Feagan; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

3.  Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease.

Authors:  Alexandra Gutierrez; Hang Lee; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

Review 4.  Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.

Authors:  Irmgard E Kronberger; Ivo W Graziadei; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 5.  Surgical therapy of perianal Crohn's disease.

Authors:  B Singh; B D George; N J McC Mortensen
Journal:  Dig Liver Dis       Date:  2007-08-27       Impact factor: 4.088

Review 6.  Nutrition and management of enterocutaneous fistula.

Authors:  D A J Lloyd; S M Gabe; A C J Windsor
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

7.  The influence of disease at the margin of resection on the outcome of Crohn's disease.

Authors:  R Heuman; B Boeryd; T Bolin; R Sjödahl
Journal:  Br J Surg       Date:  1983-09       Impact factor: 6.939

8.  Infliximab: lack of efficacy on perforating complications in Crohn's disease.

Authors:  Wolfgang Miehsler; Walter Reinisch; Lili Kazemi-Shirazi; Clemens Dejaco; Gottfried Novacek; Peter Ferenci; Friedrich Herbst; Judith Karner; Béla Téleky; Ewald Schober; Harald Vogelsang
Journal:  Inflamm Bowel Dis       Date:  2004-01       Impact factor: 5.325

9.  Crohn's disease: are enteroenteral fistulas an indication for surgery?

Authors:  P J Broe; T M Bayless; J L Cameron
Journal:  Surgery       Date:  1982-03       Impact factor: 3.982

Review 10.  Rectovaginal fistula in Crohn's disease.

Authors:  S M Andreani; H H Dang; P Grondona; A Z Khan; D P Edwards
Journal:  Dis Colon Rectum       Date:  2007-09-11       Impact factor: 4.585

View more
  20 in total

1.  CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease.

Authors:  Shrinivas Bishu; Mohammed El Zaatari; Atsushi Hayashi; Guoqing Hou; Nicole Bowers; Jami Kinnucan; Beth Manoogian; Michelle Muza-Moons; Min Zhang; Helmut Grasberger; Charlie Bourque; Weiping Zou; Peter D R Higgins; Jason R Spence; Ryan W Stidham; Nobuhiko Kamada; John Y Kao
Journal:  J Crohns Colitis       Date:  2019-07-25       Impact factor: 9.071

2.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

3.  First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study.

Authors:  Raquel Sanz-Baro; Mariano García-Arranz; Hector Guadalajara; Paloma de la Quintana; Maria Dolores Herreros; Damián García-Olmo
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

4.  MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults.

Authors:  Anuradha Shenoy-Bhangle; Katherine Nimkin; Dana Goldner; William F Bradley; Esther J Israel; Michael S Gee
Journal:  Pediatr Radiol       Date:  2013-09-05

5.  Surgical Recurrence at Anastomotic Site After Bowel Resection in Crohn's Disease: Comparison of Kono-S and End-to-end Anastomosis.

Authors:  Norimitsu Shimada; Hiroki Ohge; Toru Kono; Ayumu Sugitani; Raita Yano; Yusuke Watadani; Kenichiro Uemura; Yoshiaki Murakami; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2018-10-23       Impact factor: 3.452

6.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

7.  Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.

Authors:  David Meriwether; Dawoud Sulaiman; Carmen Volpe; Anna Dorfman; Victor Grijalva; Nasrin Dorreh; R Sergio Solorzano-Vargas; Jifang Wang; Ellen O'Connor; Jeremy Papesh; Muriel Larauche; Hannah Trost; Mayakonda N Palgunachari; G M Anantharamaiah; Harvey R Herschman; Martin G Martin; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Clin Invest       Date:  2019-06-11       Impact factor: 19.456

Review 8.  A review of the impact of biologics on surgical complications in Crohn's disease.

Authors:  Melissa I Chang; Benjamin L Cohen; Alexander J Greenstein
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

9.  Crohn's Disease Differentially Affects Region-Specific Composition and Aerotolerance Profiles of Mucosally Adherent Bacteria.

Authors:  Nur M Shahir; Jeremy R Wang; E Ashley Wolber; Matthew S Schaner; Daniel N Frank; Diana Ir; Charles E Robertson; Nicole Chaumont; Timothy S Sadiq; Mark J Koruda; Reza Rahbar; B Darren Nix; Rodney D Newberry; R Balfour Sartor; Shehzad Z Sheikh; Terrence S Furey
Journal:  Inflamm Bowel Dis       Date:  2020-11-19       Impact factor: 5.325

10.  Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease.

Authors:  Ilse Molendijk; Marjolijn Duijvestein; Andrea E van der Meulen-de Jong; Welmoed K van Deen; Marloes Swets; Daniel W Hommes; Hein W Verspaget
Journal:  J Allergy (Cairo)       Date:  2012-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.